Arrowstreet Capital Limited Partnership Has $242.98 Million Stock Position in Nutrien Ltd. (NYSE:NTR)

Arrowstreet Capital Limited Partnership grew its stake in Nutrien Ltd. (NYSE:NTR - Free Report) by 159.5% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 5,435,627 shares of the company's stock after purchasing an additional 3,341,169 shares during the period. Arrowstreet Capital Limited Partnership owned approximately 1.11% of Nutrien worth $242,976,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other hedge funds and other institutional investors have also recently bought and sold shares of NTR. Fairway Wealth LLC purchased a new position in Nutrien in the fourth quarter valued at $27,000. HHM Wealth Advisors LLC raised its holdings in shares of Nutrien by 331.0% in the fourth quarter. HHM Wealth Advisors LLC now owns 625 shares of the company's stock valued at $28,000 after buying an additional 480 shares during the last quarter. Assetmark Inc. grew its position in Nutrien by 1,437.5% in the 4th quarter. Assetmark Inc. now owns 738 shares of the company's stock valued at $33,000 after buying an additional 690 shares during the last quarter. Asset Planning Inc acquired a new position in Nutrien during the 4th quarter worth approximately $35,000. Finally, Exchange Traded Concepts LLC lifted its holdings in Nutrien by 96.7% in the fourth quarter. Exchange Traded Concepts LLC now owns 846 shares of the company's stock valued at $38,000 after acquiring an additional 416 shares during the period. 63.10% of the stock is currently owned by institutional investors and hedge funds.

Nutrien Trading Up 1.6 %

Shares of Nutrien stock traded up $0.78 on Thursday, hitting $50.73. 1,633,825 shares of the company's stock traded hands, compared to its average volume of 2,023,686. Nutrien Ltd. has a one year low of $43.70 and a one year high of $60.87. The company has a debt-to-equity ratio of 0.38, a current ratio of 1.27 and a quick ratio of 0.82. The stock has a market capitalization of $24.80 billion, a PE ratio of 37.03, a price-to-earnings-growth ratio of 1.19 and a beta of 0.81. The firm's 50-day moving average price is $51.47 and its two-hundred day moving average price is $49.07.

Nutrien (NYSE:NTR - Get Free Report) last announced its quarterly earnings results on Wednesday, February 19th. The company reported $0.28 EPS for the quarter, missing analysts' consensus estimates of $0.37 by ($0.09). Nutrien had a net margin of 2.62% and a return on equity of 6.81%. The company had revenue of $5.08 billion during the quarter, compared to the consensus estimate of $5.09 billion. On average, research analysts expect that Nutrien Ltd. will post 3.72 EPS for the current fiscal year.

Nutrien Cuts Dividend

The firm also recently declared a quarterly dividend, which will be paid on Thursday, April 10th. Stockholders of record on Monday, March 31st will be paid a dividend of $0.545 per share. The ex-dividend date of this dividend is Monday, March 31st. This represents a $2.18 annualized dividend and a dividend yield of 4.30%. Nutrien's dividend payout ratio is currently 159.12%.

Analyst Ratings Changes

Several analysts have issued reports on the stock. Royal Bank of Canada reaffirmed an "outperform" rating and issued a $60.00 price target on shares of Nutrien in a report on Monday, February 24th. JPMorgan Chase & Co. raised shares of Nutrien from an "underweight" rating to a "neutral" rating and increased their target price for the stock from $40.00 to $50.00 in a research report on Monday, January 13th. Piper Sandler raised their target price on Nutrien from $58.00 to $63.00 and gave the company an "overweight" rating in a report on Monday, January 27th. UBS Group lifted their target price on Nutrien from $53.00 to $54.00 and gave the stock a "neutral" rating in a research report on Thursday, February 20th. Finally, The Goldman Sachs Group initiated coverage on shares of Nutrien in a research report on Thursday, March 13th. They set a "sell" rating and a $53.00 price target on the stock. Two investment analysts have rated the stock with a sell rating, five have assigned a hold rating and eight have given a buy rating to the company's stock. According to MarketBeat, the stock presently has a consensus rating of "Hold" and an average target price of $60.00.

About Nutrien

Nutrien Ltd. provides crop inputs and services. The company operates through four segments: Retail, Potash, Nitrogen, and Phosphate. The Retail segment distributes crop nutrients, crop protection products, seeds, and merchandise products. The Potash segment provides granular and standard potash products.